YONG PAK: Open Payments
NPI 1437738986 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 22 payments from 7 companies in 2025. Trend: 2023 $121 · 2024 $442 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $635 |
| Novo Nordisk Inc | 4 | $175 |
| ViiV Healthcare Company | 3 | $158 |
| Astellas Pharma US Inc | 3 | $90 |
| Agios Pharmaceuticals, Inc. | 2 | $60 |
| Exact Sciences Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
Products named: BREZTRI, CABENUVA, AIRSUPRA, Veozah, PYRUKYND, FARXIGA, Ozempic, Rybelsus.
Industry payments across NY — which companies pay providers there.
